Numerous clinical studies have confirmed that a diet that mimics fasting can improve the efficacy of neoadjuvant therapy in patients with HER2-negative BC and improve the quality of life of patients with ovarian cancer and BC who receive chemotherapy (91, 92). The gene discussed is ERBB2; the disease is ovarian carcinoma.